CD4+ T cells play a pivotal role in the control of cowpox virus infection in mice

Viral Immunology

Volumn 20, Issue 1, 2007, Pages 214-220

  Ferrier Rembert, A ^a   Tournier, J N ^a   Drillien, R ^b   Garin, D ^a   Crange, J M ^a  

^a Centre de Recherches du Service de Sante des Armees   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; COWPOX VIRUS; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COWPOX; FEMALE; MICE; MICE, INBRED BALB C;

COWPOX VIRUS; MUS;

EID: 34247181223     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0091     Document Type: Article

References (18)

1. Alibek K: The Soviet Union's anti-agricultural biological weapons. Ann N Y Acad Sci 1999;894:18-19.
2. Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, and Berzofsky JA: Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA 2003;100:9458-9463.
3. Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, and Huggins JW: Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis 2000;181:10-19.
4. Chaudhri G, Panchanathan V, Bluethmann H, and Karupiah G: Obligatory requirement for antibody in recovery from a primary poxvirus infection. J Virol 2006;80:6339-6344.
5. Coulibaly S, Bruhl P, Mayrhofer J, Schmid K, Gerencer M, and Falkner FG: The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection. Virology 2005;341:91-101.
6. European Medicines Agency: Note for Guidance on the Development of Vaccinia Virus Based Vaccines against Smallpox. 2002. Available at URL http://www.emea.europa.eu/pdfs/human/vwp/110002en.pdf (accessed February 2006).
7. Esposito J, and Fenner F: Poxviruses. In Fields Virology, Knipe DM, and Howley PM, eds. Lippincott Williams & Wilkins, Philadelphia, 2001, pp. 2885-2921
8. + T cell responses. Eur J Immunol 2005;35:2532-2540.
9. + T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol 2005;175:6829-6836.
10. Ferrier-Rembert A, Drillien R, Tournier JN, Garin D, and Crance JM: Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines. Vaccine (in press).
11. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 1996;70:8301-8309.
12. Leparc-Goffart I, Poirier B, Garin D, Tissier MH, Fuchs F, and Crance JM: Standardization of a neutralizing anti-vaccinia antibodies titration method: An essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation. J Clin Virol 2005;32:47-52.
13. Martinez MJ, Bray MP, and Huggins JW: A mouse model of aerosol-transmitted orthopoxviral disease: Morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system. Arch Pathol Lab Med 2000;124:362-77.
14. Panchanathan V, Chaudhri G, and Karupiah G: Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 2006;80:6333-6338.
15. Smee DF, Bailey KW, Wong M, and Sidwell RW: Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res 2000;47:171-177.
16. Smee DF, and Sidwell RW: A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res 2003;57:41-52.
17. Tournier JN, Hellmann AQ, Lesca G, Jouan A, Drouet E, and Mathieu J: Fever-like thermal conditions regulate the activation of maturing dendritic cells. J Leukoc Biol 2003;73:493-501.
18. Xu R, Johnson AJ, Liggitt D, and Bevan MJ: Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 2004;172:6265-6271.